about
Quality assurance guidelines for superficial hyperthermia clinical trials : II. Technical requirements for heating devices.Impaired myocardial function does not explain reduced left ventricular filling and stroke volume at rest or during exercise at high altitudeQuality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements.Thermal Skin Damage During Reirradiation and Hyperthermia Is Time-Temperature Dependent.Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m.Cerebral pressure–flow relationship in lowlanders and natives at high altitude.Dynamic weight loading in older people with hip fracture.A flexible 70 MHz phase-controlled double waveguide system for hyperthermia treatment of superficial tumours with deep infiltration.Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia.Influence of posture on the regulation of cerebral perfusion.Hypoxia, not pulmonary vascular pressure, induces blood flow through intrapulmonary arteriovenous anastomoses.Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling.Thermal dosimetry for bladder hyperthermia treatment. An overview.Resting pulmonary haemodynamics and shunting: a comparison of sea-level inhabitants to high altitude SherpasThe effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patientsClinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic regionAnalysis of clinical data to determine the minimum number of sensors required for adequate skin temperature monitoring of superficial hyperthermia treatmentsTwo high-resolution thermal monitoring sheets for clinical superficial hyperthermia
P50
Q30357008-BC314F41-E9FC-4956-8CF1-4CACA065418CQ30369886-D04E6355-3FD1-4260-BF94-248151175AFBQ36238725-124D3F18-36B8-4792-990B-21ABBADA012FQ40219070-0A6ADB81-1C9C-43E6-A0B9-D28980F6EB24Q45265171-041C45FF-E2C5-4ED4-BBB5-B94F650B0238Q45774562-8B1A4393-10F8-453E-B93B-63CFF810DA2FQ47176467-BAD1CB51-CD00-4D9B-B731-EF59A132CEDFQ48029533-39F5BBF9-2C84-4E47-AF48-8BDFE4D3140DQ48036068-50C37954-C645-47A5-A21E-E75F59CEE444Q48289596-A44C864C-BFA0-4437-947B-3BFDD243C2C4Q48416517-B1458584-A3FD-4712-8634-3412F5286A76Q48807212-A46490C2-70B6-4989-A380-3494BF41A7AFQ51122913-1884A7BD-81BE-405C-AC91-D5B2C0544CADQ51350066-098B96B0-F9C5-4FD1-AEF2-B5C27631044CQ57096728-11FCE95B-37C1-448C-976A-2DB642FF9B7BQ57284170-8F471B8D-A486-46F5-994B-06505BCB8255Q58080946-D50E6F28-3121-4045-89F2-ED30696D13E3Q88367335-F31F56F1-578A-4EC2-AB3C-C92B55D6FA77Q96293939-653DD067-DE00-4347-AFEA-EBA9A477371E
P50
description
researcher ORCID ID = 0000-0002-3370-7710
@en
wetenschapper
@nl
name
Akke Bakker
@ast
Akke Bakker
@en
Akke Bakker
@es
Akke Bakker
@nl
type
label
Akke Bakker
@ast
Akke Bakker
@en
Akke Bakker
@es
Akke Bakker
@nl
prefLabel
Akke Bakker
@ast
Akke Bakker
@en
Akke Bakker
@es
Akke Bakker
@nl
P1153
56903702700
P31
P496
0000-0002-3370-7710